All stock lists
Nurix Therapeutics, Inc. (NASDAQ:NRIX)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
25.49+0.15 (+0.61%)
Insider Score
––Not scored
NRIX Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
NRIX Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Aug 31, 2026 | May 31, 2026 | Feb 28, 2026 | Nov 30, 2025 | Aug 31, 2025 | May 31, 2025 |
| Revenue | 673.06 M | 9.04 M | 6.25 M | 13.58 M | 7.89 M | 44.06 M |
| Revenue Growth (YoY) | 8426.27 % | -79.47 % | -66.12 % | 2.21 % | -37.29 % | 264.34 % |
| Cost of Revenue | 2.14 M | 3.85 M | 84.14 M | 4.63 M | 5.00 M | 78.10 M |
| Gross Profit | 670.92 M | 5.19 M | -77.89 M | 8.95 M | 2.89 M | -34.04 M |
| SG&A Expense | 34.35 M | 15.59 M | 14.61 M | 13.65 M | 13.16 M | 14.28 M |
| R&D Expense | 79.26 M | 87.65 M | 84.14 M | 80.90 M | 86.12 M | 78.10 M |
| Operating Expenses | 111.47 M | 99.40 M | 14.61 M | 92.04 M | 94.28 M | 14.28 M |
| Operating Income | 559.45 M | -94.20 M | -92.50 M | -83.09 M | -91.39 M | -48.32 M |
| Pretax Income | 563.41 M | -89.81 M | -87.17 M | -78.22 M | -86.42 M | -42.70 M |
| Tax Provision | 13.61 M | -271.00 K | 0.00 | 0.00 | 0.00 | 760.00 K |
| Net Income | 549.81 M | -89.53 M | -87.17 M | -78.22 M | -86.42 M | -43.46 M |
| EPS (Basic) | 4.93 | -0.81 | -0.79 | -0.82 | -1.03 | -0.52 |
| EPS (Diluted) | 4.73 | -0.81 | -0.79 | -0.82 | -1.03 | -0.52 |
| Shares Outstanding | 111.56 M | 111.08 M | 110.07 M | 95.09 M | 84.16 M | 83.88 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.